ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HIK Hikma Pharmaceuticals Plc

1,913.00
59.00 (3.18%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  59.00 3.18% 1,913.00 1,916.00 1,918.00 1,920.00 1,861.00 1,861.00 522,491 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 22.08 4.24B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,854p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.24 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.08.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1651 to 1669 of 1875 messages
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older
DateSubjectAuthorDiscuss
07/6/2022
13:43
Need some decent news ffs.Wht is the chairman doing
scepticalinvestor
01/6/2022
09:27
Give it time...the BB will eventually move this up
scepticalinvestor
26/5/2022
10:57
Get a good CEO in, may get up to Barclays target 2800p.
montyhedge
25/5/2022
09:14
Just shows the irrelevance of them and thus the irrelevance of reposting them repeatedly!
blue59
25/5/2022
08:38
Barclays have buy 2800p, another broker 1900p, lol.
montyhedge
25/5/2022
08:20
JPM cuts to neutral from overweight.
sza2002
25/5/2022
08:09
Surely a TO target now one wld think
scepticalinvestor
24/5/2022
20:31
Wonder why the rns wasn't better worded then.
Suet

suetballs
24/5/2022
20:17
You're right.
Probably the best man to turn things around - and still fairly young at 65.
Suet

suetballs
24/5/2022
20:06
I stand corrected there's a news article saying they are searching for a new ceo apologies
dartboard1
24/5/2022
19:50
They didn't say interim ... rns said he will assume ceo responsibilities ... no mention of searching for new ceo
dartboard1
24/5/2022
19:33
Yes but he’ll only be temporary.
Suet

suetballs
24/5/2022
19:31
The new ceo is the large shareholder
dartboard1
24/5/2022
18:54
Probably under pressure by large shareholders to get someone new in.
montyhedge
24/5/2022
18:02
Just maybe ‘getting rid’ of the ceo will see an improvement in fortunes here. Hope so.
Suet

suetballs
24/5/2022
15:26
Could be worst could be in Nasdaq tech stocks.
montyhedge
24/5/2022
15:13
PS But don’t forget the dividend LMFAO!!
blue59
24/5/2022
09:08
Good news, get someone more dynamic and get the shareprice going.Astra boss would be good, lol.
montyhedge
24/5/2022
08:53
I suspect the indifferent share price performance had something to do with it.
Prompt resignation - no replacement in the wings - indicates disagreements to me.
Suet

suetballs
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older

Your Recent History

Delayed Upgrade Clock